This review synthesizes current evidence from functional magnetic resonance imaging (fMRI) studies to elucidate the complex interplay between craving and executive function in substance use disorders.
This article synthesizes current research on the neurobiological basis of individual differences in addiction vulnerability, progression, and treatment response.
This article examines the critical challenges and emerging solutions in translating advances in addiction neuroscience into effective clinical treatments for substance use disorders (SUDs).
This article synthesizes the latest advancements in addiction neuroscience to provide a strategic overview for researchers and drug development professionals.
This article provides a comprehensive overview for researchers and drug development professionals on how computational modeling is revolutionizing our understanding of dopaminergic dysfunction in addiction.
The Addictions Neuroclinical Assessment (ANA) is a transformative, neuroscience-based framework designed to address the profound clinical heterogeneity of Substance Use Disorders (SUDs) by focusing on three core neurofunctional domains: Incentive...
Substance use disorders (SUDs) represent a major global health challenge with high relapse rates despite available treatments.
This article provides a comprehensive analysis of the neurobiological underpinnings of addiction and the pharmacotherapies designed to target them.
This article provides a comprehensive analysis of the translation of neuroscientific findings into clinical practices for addiction treatment, tailored for researchers, scientists, and drug development professionals.
This article provides a comprehensive overview of how optogenetic and chemogenetic technologies are revolutionizing our understanding of the neural circuits underlying addiction.